Wordt geladen...
Adjuvant capecitabine plus oxaliplatin after D2 gastrectomy in Japanese patients with gastric cancer: a phase II study
BACKGROUND: Adjuvant chemotherapy with XELOX (capecitabine plus oxaliplatin) has been shown to be beneficial following resection of gastric cancer in South Korean, Chinese, and Taiwanese patients. This phase II study (J-CLASSIC-PII) was undertaken to evaluate the feasibility of XELOX in Japanese pat...
Bewaard in:
Gepubliceerd in: | Gastric Cancer |
---|---|
Hoofdauteurs: | , , , , , , , , , , , , , , , , |
Formaat: | Artigo |
Taal: | Inglês |
Gepubliceerd in: |
Springer Japan
2016
|
Onderwerpen: | |
Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5321693/ https://ncbi.nlm.nih.gov/pubmed/26956689 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10120-016-0606-4 |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|